Department of Digestive Surgery, Hôpital Charles Nicolle, Rouen University Hospital, Rouen Cedex, France.
Department of Biostatistics, Hôpital Charles Nicolle, Rouen University Hospital, Rouen, France.
Ann Surg Oncol. 2020 Sep;27(9):3383-3392. doi: 10.1245/s10434-020-08442-5. Epub 2020 Apr 13.
Spontaneous rupture of hepatocellular carcinoma (HCC) remains a life-threatening complication, with a reported mortality rate of between 16 and 30% and an incidence rate of approximately 3% in Europe. Survival data and risk factors after ruptured HCC are lacking, especially for peritoneal metastasis (PM).
The aims of this study were to evaluate the pattern of recurrence and mortality after hepatectomy for ruptured HCC, and to focus on PM.
We retrospectively reviewed the files of patients admitted to 14 French surgical centers for spontaneous rupture of HCC between May 2000 and May 2012.
Overall, 135 patients were included in this study. The median disease-free survival and overall survival (OS) rates were 16.1 (11.0-21.1) and 28.7 (26.0-31.5) months, respectively, and the median follow-up period was 29 months. At last follow-up, recurrences were observed in 65.1% of patients (n = 88). The overall rate of PM following ruptured HCC was 12% (n = 16). Surgical management of PM was performed for six patients, with a median OS of 36.6 months. An α-fetoprotein level > 30 ng/mL (p = 0.0009), tumor size at rupture > 70 mm (p = 0.0009), and vascular involvement (p < 0.0001) were found to be independently associated with an increased likelihood of recurrence. No risk factor for PM was observed.
This large-cohort French study confirmed that 12% of patients had PM after ruptured HCC. A curative approach may be an option for highly selected patients with exclusive PD because of the survival benefit it could provide.
肝细胞癌(HCC)自发破裂仍是一种危及生命的并发症,据报道,其死亡率在 16%至 30%之间,在欧洲的发病率约为 3%。破裂后 HCC 的生存数据和危险因素尚不清楚,特别是对于腹膜转移(PM)。
本研究旨在评估破裂后 HCC 行肝切除术后的复发和死亡率模式,并重点关注 PM。
我们回顾性分析了 2000 年 5 月至 2012 年 5 月期间,14 家法国外科中心收治的自发性 HCC 破裂患者的病历。
总体而言,本研究纳入了 135 例患者。无病生存和总生存(OS)率的中位数分别为 16.1(11.0-21.1)和 28.7(26.0-31.5)个月,中位随访时间为 29 个月。末次随访时,65.1%(n=88)的患者出现复发。破裂后 HCC 的总体 PM 发生率为 12%(n=16)。对 6 例 PM 患者进行了手术治疗,中位 OS 为 36.6 个月。AFP 水平>30ng/mL(p=0.0009)、破裂时肿瘤大小>70mm(p=0.0009)和血管受累(p<0.0001)是复发可能性增加的独立相关因素。未观察到 PM 的危险因素。
这项大型法国队列研究证实,破裂后 HCC 患者中有 12%发生 PM。由于生存获益,对于仅有 PD 的高度选择患者,根治性方法可能是一种选择。